MDlaw – Information platform on European medical device regulations MDlaw – Information platform on European medical device regulations
  • News
  • Library of documents
  • RA Map
  • Webinars
  • Store
  • About & More
    • About us
    • Our network
    • Sponsored Content
    • Call for Authors & Reviewers
    • Obelis Group – Certificate Database
    • Advertise with us
  • Log In
BECOME A MEMBER
0
MDR

MDCG Guidance on Period Safety Update Report (PSUR) under MDR

on December 16, 2022

Manufacturers of class IIa, class IIb, and class III medical devices have to prepare a Period Safety Update Report (PSUR) for each device or group of device. Manufacturers of class I medical devices do not have to prepare a PSUR, but a PMS report instead. With article 86, the Medical Devices Regulation (MDR) introduced this requirement.

In December 2022, the Medical Device Coordination Group (MDCD) published a Oh! It looks like you do not have access to this page.
Find the membership plan that suits you, and within a few minutes you are good to go.
Are you a member already? Log in here.

Basic UDI-DI benefit-risk analysis EUDAMED guidance Legacy devices MDR requirements Period Safety Update Report PMCF PMS post-market clinical follow-up PSUR
Recent Posts
  • Conformity assessment: Annual report on Clinical Evaluation Consultation Procedures (CECP) January 23, 2023
  • MDR: 37th Notified Body on NANDO! January 20, 2023
  • Notified Body: templates for Lists of Standard Fees January 13, 2023
  • How MDCG 2022-18 applies in Switzerland: certification gaps and notification January 13, 2023
  • MDCG Guidance on Article 5 (5) of MDR & IVDR! January 10, 2023
Categories
  • IVDR
  • MDR
  • UDI
  • Uncategorized
Previous Post (p) MDCG template for substantial modification of performance study
Next Post (n) MDR & IVDR: Update to Manual on borderline classification!

Related News

How MDCG 2022-18 applies in Switzerland: certification gaps and notification

Simona Varrella 2023-01-13T11:58:22+01:00

Legacy devices: European Commission adopts proposal to extend Transitional period & Certificates!

regulatory26@obelis.net 2023-01-06T14:53:15+01:00

MDCG template for substantial modification of performance study

Simona Varrella 2022-12-15T11:56:53+01:00
Simona Varrella 2022-12-16T17:14:54+01:00

© MDlaw.
Privacy policy.

  • Become a member
  • Products
  • Webinars

MDlaw.eu
mdlaw@obelis.net
+32(0)2 7325954

Disclaimer: The content on this website does not provide legal advice and is for information purpose only. Obelis accepts no liability for any inaccuracies or omissions in the information in its website and any decisions based on such are under the sole responsibility of the reader.

Powered by Obelis Group

  • News
  • Library of documents
  • RA Map
  • Webinars
  • Store
  • About & More
    • About us
    • Our network
    • Sponsored Content
    • Call for Authors & Reviewers
    • Obelis Group – Certificate Database
    • Advertise with us
  • Log In
Shopping Bag

Welcome to MDlaw, the most extensive and up-to-date information base on European MDR and IVDR laws. We collect cookies.

I accept